What is Anima?
Founded in 2021, Anima provides an automated, always-on triage solution designed to optimize patient care delivery. By integrating seamlessly into primary care environments, the platform enables clinicians to process consultations and patient inquiries significantly faster than traditional teletriage or e-consultation methods. The company's core value proposition lies in its ability to reduce the administrative burden on healthcare providers, thereby improving both clinical outcomes and patient satisfaction. As a leader in the HealthTech space, Anima leverages advanced automation to solve the persistent issue of high workload in primary care, effectively bridging the gap between patient demand and clinical capacity.
How much funding has Anima raised?
Anima has raised a total of $14.5M across 2 funding rounds:
Angel/Seed
$2.5M
Series A
$12M
Angel/Seed (2021): $2.5M with participation from Hummingbird Ventures and Amino Collective
Series A (2024): $12M led by Molten, Y Combinator, and Hummingbird Ventures
Key Investors in Anima
Molten
Molten is a London-based venture capital firm that specializes in backing high-growth technology companies with global ambitions, providing the necessary capital to scale operations effectively.
Y Combinator
Based in Mountain View, California, Y Combinator is a premier startup accelerator that provides seed funding and strategic mentorship to early-stage companies with high growth potential.
Hummingbird Ventures
Hummingbird Ventures is a global investment fund that focuses on backing outlier founders at the earliest stages, offering significant support throughout the entire lifecycle of their portfolio companies.
What's next for Anima?
Looking ahead, the strategic deployment of the $12M will likely focus on scaling Anima's operational capabilities and deepening its integration within existing healthcare frameworks. As the company transitions from its early-stage development into a more mature scaling phase, the focus will shift toward broader market adoption and the refinement of its triage algorithms. By maintaining its commitment to clinician-led design, Anima is poised to set new standards for efficiency in primary care. The continued support from high-profile investors suggests a long-term vision for the company to become an essential component of the digital health ecosystem, potentially expanding its reach beyond the UK market to address global primary care challenges.
See full Anima company page
